Switching acute coronary syndrome patients from prasugrel to clopidogrel.

JACC. Cardiovascular interventions

Volumn 6, Issue 2, 2013, Pages 158-165

  Kerneis, Mathieu ^a   Silvain, Johanne ^b   Abtan, Jérémie ^b   Cayla, Guillaume ^b   O'Connor, Stephen A ^b   Barthélémy, Olivier ^b   Vignalou, Jean Baptiste ^b   Beygui, Farzin ^b   Brugier, Delphine ^b   Martin, Réjane ^b   Collet, Jean Philippe ^b   Montalescot, Gilles ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CLOPIDOGREL; DRUG DERIVATIVE; P2RY12 PROTEIN, HUMAN; PHOSPHOPROTEIN; PIPERAZINE DERIVATIVE; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR; THIOPHENE DERIVATIVE; TICLOPIDINE; VASODILATOR STIMULATED PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLEEDING; BLOOD; BLOOD CLOTTING PARAMETERS; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; DRUG EFFECT; DRUG RESISTANCE; DRUG SUBSTITUTION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE; TIME; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL ADHESION MOLECULES; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE; DRUG SUBSTITUTION; FEMALE; HEMORRHAGE; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; PHOSPHORYLATION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; THIOPHENES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84881283025     PISSN: None     EISSN: 18767605     Source Type: None    
DOI: 10.1016/j.jcin.2012.09.012     Document Type: Article

References (0)